TRIM9 antibody (C-Term)
Quick Overview for TRIM9 antibody (C-Term) (ABIN202749)
Target
See all TRIM9 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term
-
Specificity
- Human TRIM9
-
Predicted Reactivity
- Percent identity by BLAST analysis: Human (100%) Rabbit (92%).
-
Purification
- Protein A purified
-
Immunogen
-
Synthetic peptide from C-Terminus of human TRIM9 (Q9C026-5, NP_443210). Percent identity by BLAST analysis: Human, Chimpanzee (100%), Rabbit (92%).
Type of Immunogen: Synthetic peptide -
Isotype
- IgG
-
-
-
-
Application Notes
- Approved: WB (2.5 μg/mL)
-
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Reconstitute with 100 μL deionized water
-
Concentration
- Lot specific
-
Buffer
- Lyophilized from PBS with 2 % sucrose
-
Handling Advice
- Avoid repeat freeze-thaw cycles.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
-
- TRIM9 (Tripartite Motif Containing 9 (TRIM9))
-
Alternative Name
- SPRING / TRIM9
-
Background
-
Name/Gene ID: TRIM9
Family: Tripartite Motif
Synonyms: TRIM9, KIAA0282, RING finger protein 91, SPRING, Tripartite motif containing 9, RNF91, Tripartite motif-containing 9 -
Gene ID
- 114088
-
NCBI Accession
- NP_443210
-
UniProt
- Q9C026
-
Pathways
- Synaptic Vesicle Exocytosis
Target
-